Inactive Instrument

Highlights Sartorius Aktiengesellschaft Other OTC

Equities

Ailing hospitals slow down German medical technology sector	05-23	DP
JPMorgan lowers target for Sartorius to 330 euros - 'Overweight'	05-22	DP
Sartorius Partners with Nvidia on Drug Discovery, Manufacturing Using AI	05-16	MT
Sartorius sinks again towards year low	05-16	DP
Sartorius Partners With Sanofi for Biomanufacturing Platform	05-13	MT
SARTORIUS : Target cut by -6.1%	04-30
US competitor Danaher boosts Merck KGaA and Sartorius	04-23	DP
SARTORIUS : Q1 24: Top-line miss but a few positives	04-22
German Shares Close Green as Bundesbank Sees Q1 Economic Growth	04-18	MT
FTSE 100 up despite hawkish Fed rates outlook	04-18	AN
Sartorius continues recovery after weak start - share price slide	04-18	DP
Sartorius Aktiengesellschaft Reports Earnings Results for the First Quarter Ended March 31, 2024	04-18	CI
Sartorius and subsidiary Stedim under pressure after weak figures	04-18	DP
Sartorius Shares Slide on Revenue, Profit Decline	04-18	DJ
UBS rates Sartorius 'Neutral' - Target 366 euros	04-18	DP
Industrials drive STOXX 600 higher as earnings season gathers steam	04-18	RE
Sartorius Posts Lower Q1 Attributable Profit, Sales Revenue	04-18	MT
Sartorius gets off to a slow start to the year - still hoping for recovery	04-18	DP
Correction: Germany’s Sartorius Strikes Partnership with US-based TheWell Bioscience	04-09	MT
Germany’s Sartorius Strikes Partnership with US-based TheWell Bioscience	04-09	MT

No results for this search

SARTORIUS : Target cut by -6.1%

April 30, 2024 at 12:35 pm